Queen Sirikit Centre for Breast Cancer
Bangkok, 10330, Thailand
NCT Number: NCT03052621
Locally advance breast cancer and extensive locoregional recurrence are still considered as complexity of reconstruction. Although previous studies concluded that omental transposition was considerably indicated in poor vascularity in irradiated tissue, secondary infection and large defect become the obstacles of local tissue flaps. While some centres showed the excellent healing of omental transposition. Meanwhile, many studies showed the preferable outcome in escalating radiotherapy in term of locoregional control. In the investigators' institute, omental transposition in breast cancer has been developed for twenty years. The only institute in Thailand enhanced using this procedure in order to closure of large primary breast cancer and chest wall recurrence. This procedure is undertaken by single surgeon (Dr. K.J.). The investigators' protocol of omental transposition is including preoperative chemotherapy, preoperative accelerated radiation up to 80 Gy, approval of breast cancer centre committee, and meticulous wound care including vacuum assisted wound dressing, non-adhesive dressing. As a result, survival time could be improved.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Bangkok, 10330, Thailand
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Harvesting the omentum to cover irradiated defects of breast cancer
Other names: Omental graft
Time frame: 22 years
Queen Sirikit Centre for Breast Cancer
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07418138
Adenocarcinoma, Carcinoma
Xi'an, Shaanxi, China
View Trial DetailsNCT06989346
Colorectal Surgery, Disease Attributes
Barcelona, Catalonia, Spain
View Trial DetailsNCT06095843
Crestal Bone Loss, Survival Rate
Cairo, Egypt
View Trial DetailsNCT00748358
Disease-Free Survival, Genital Diseases
Paris, France
View Trial Details